nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—RXRA—thyroid cancer	0.717	1	CbGaD
Acitretin—CYP26A1—trachea—thyroid cancer	0.00387	0.125	CbGeAlD
Acitretin—RXRG—neck—thyroid cancer	0.00347	0.112	CbGeAlD
Acitretin—Isotretinoin—RXRA—thyroid cancer	0.00271	0.418	CrCbGaD
Acitretin—Alitretinoin—RXRA—thyroid cancer	0.00221	0.341	CrCbGaD
Acitretin—RBP1—thyroid gland—thyroid cancer	0.00183	0.0588	CbGeAlD
Acitretin—RARB—thyroid gland—thyroid cancer	0.00169	0.0544	CbGeAlD
Acitretin—RXRA—head—thyroid cancer	0.00167	0.0538	CbGeAlD
Acitretin—RXRG—thyroid gland—thyroid cancer	0.00165	0.0532	CbGeAlD
Acitretin—RBP1—head—thyroid cancer	0.00162	0.0522	CbGeAlD
Acitretin—Tretinoin—RXRA—thyroid cancer	0.00156	0.24	CrCbGaD
Acitretin—RXRB—thyroid gland—thyroid cancer	0.00155	0.05	CbGeAlD
Acitretin—RARB—head—thyroid cancer	0.0015	0.0483	CbGeAlD
Acitretin—RXRG—head—thyroid cancer	0.00147	0.0472	CbGeAlD
Acitretin—RARG—thyroid gland—thyroid cancer	0.00138	0.0444	CbGeAlD
Acitretin—RXRB—head—thyroid cancer	0.00138	0.0444	CbGeAlD
Acitretin—RARA—thyroid gland—thyroid cancer	0.0013	0.0418	CbGeAlD
Acitretin—RARG—head—thyroid cancer	0.00122	0.0394	CbGeAlD
Acitretin—RARA—head—thyroid cancer	0.00115	0.037	CbGeAlD
Acitretin—RBP1—lymph node—thyroid cancer	0.00114	0.0366	CbGeAlD
Acitretin—RARB—lymph node—thyroid cancer	0.00105	0.0338	CbGeAlD
Acitretin—RARG—lymph node—thyroid cancer	0.000857	0.0276	CbGeAlD
Acitretin—RARA—lymph node—thyroid cancer	0.000806	0.0259	CbGeAlD
Acitretin—ALB—lymph node—thyroid cancer	0.000454	0.0146	CbGeAlD
Acitretin—RARG—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000442	0.00357	CbGpPWpGaD
Acitretin—RXRG—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000404	0.00327	CbGpPWpGaD
Acitretin—CYP26A1—Adipogenesis—RXRA—thyroid cancer	0.0004	0.00323	CbGpPWpGaD
Acitretin—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—thyroid cancer	0.000397	0.00321	CbGpPWpGaD
Acitretin—RARB—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000396	0.0032	CbGpPWpGaD
Acitretin—RBP1—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.000396	0.0032	CbGpPWpGaD
Acitretin—RARG—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000394	0.00318	CbGpPWpGaD
Acitretin—RXRA—Transcription factor regulation in adipogenesis—PPARG—thyroid cancer	0.000388	0.00314	CbGpPWpGaD
Acitretin—RXRB—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00038	0.00307	CbGpPWpGaD
Acitretin—RARA—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00038	0.00307	CbGpPWpGaD
Acitretin—ALB—Recycling of bile acids and salts—RXRA—thyroid cancer	0.000362	0.00292	CbGpPWpGaD
Acitretin—RXRG—Generic Transcription Pathway—TRIM33—thyroid cancer	0.00036	0.00291	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000353	0.00285	CbGpPWpGaD
Acitretin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—thyroid cancer	0.00034	0.00274	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000339	0.00274	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000339	0.00274	CbGpPWpGaD
Acitretin—CYP26A1—Biological oxidations—RXRA—thyroid cancer	0.000319	0.00258	CbGpPWpGaD
Acitretin—RBP1—Retinoblastoma (RB) in Cancer—CCND1—thyroid cancer	0.000303	0.00245	CbGpPWpGaD
Acitretin—RXRG—Adipogenesis—RXRA—thyroid cancer	0.000303	0.00245	CbGpPWpGaD
Acitretin—CYP26A1—Adipogenesis—HIF1A—thyroid cancer	0.000297	0.0024	CbGpPWpGaD
Acitretin—RBP1—Disease—TRIM24—thyroid cancer	0.000292	0.00236	CbGpPWpGaD
Acitretin—RARA—Adipogenesis—RXRA—thyroid cancer	0.000285	0.0023	CbGpPWpGaD
Acitretin—RARG—Generic Transcription Pathway—THRB—thyroid cancer	0.000285	0.0023	CbGpPWpGaD
Acitretin—RBP1—Disease—CHST14—thyroid cancer	0.000275	0.00222	CbGpPWpGaD
Acitretin—RARG—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.000267	0.00216	CbGpPWpGaD
Acitretin—RBP1—Disease—TRIM33—thyroid cancer	0.000261	0.00211	CbGpPWpGaD
Acitretin—RXRG—Generic Transcription Pathway—THRB—thyroid cancer	0.00026	0.0021	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—THRB—thyroid cancer	0.000255	0.00206	CbGpPWpGaD
Acitretin—CYP26A1—Adipogenesis—PPARG—thyroid cancer	0.000252	0.00204	CbGpPWpGaD
Acitretin—RXRA—Nuclear Receptors—PPARG—thyroid cancer	0.000251	0.00203	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—THRB—thyroid cancer	0.000245	0.00198	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—THRB—thyroid cancer	0.000245	0.00198	CbGpPWpGaD
Acitretin—RXRG—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.000244	0.00197	CbGpPWpGaD
Acitretin—RXRA—PPAR Alpha Pathway—CCND1—thyroid cancer	0.000241	0.00195	CbGpPWpGaD
Acitretin—RARB—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.00024	0.00194	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—MINPP1—thyroid cancer	0.000235	0.0019	CbGpPWpGaD
Acitretin—RXRB—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.00023	0.00186	CbGpPWpGaD
Acitretin—RARA—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.00023	0.00186	CbGpPWpGaD
Acitretin—RXRG—Adipogenesis—HIF1A—thyroid cancer	0.000225	0.00182	CbGpPWpGaD
Acitretin—RXRA—Circadian Clock—HIF1A—thyroid cancer	0.000219	0.00177	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000218	0.00176	CbGpPWpGaD
Acitretin—Dry mouth—Sorafenib—thyroid cancer	0.000218	0.00179	CcSEcCtD
Acitretin—Diarrhoea—Vandetanib—thyroid cancer	0.000216	0.00178	CcSEcCtD
Acitretin—Melaena—Epirubicin—thyroid cancer	0.000216	0.00177	CcSEcCtD
Acitretin—Creatinine increased—Doxorubicin—thyroid cancer	0.000215	0.00176	CcSEcCtD
Acitretin—Salivary hypersecretion—Epirubicin—thyroid cancer	0.000215	0.00176	CcSEcCtD
Acitretin—Influenza like illness—Epirubicin—thyroid cancer	0.000215	0.00176	CcSEcCtD
Acitretin—Bone pain—Doxorubicin—thyroid cancer	0.000214	0.00175	CcSEcCtD
Acitretin—Infection—Sorafenib—thyroid cancer	0.000212	0.00174	CcSEcCtD
Acitretin—RARA—Adipogenesis—HIF1A—thyroid cancer	0.000211	0.00171	CbGpPWpGaD
Acitretin—Candida infection—Epirubicin—thyroid cancer	0.000211	0.00173	CcSEcCtD
Acitretin—Skin exfoliation—Epirubicin—thyroid cancer	0.000211	0.00173	CcSEcCtD
Acitretin—Gait disturbance—Doxorubicin—thyroid cancer	0.00021	0.00172	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000209	0.00169	CbGpPWpGaD
Acitretin—Dizziness—Vandetanib—thyroid cancer	0.000209	0.00172	CcSEcCtD
Acitretin—Blood uric acid increased—Doxorubicin—thyroid cancer	0.000208	0.00171	CcSEcCtD
Acitretin—Skin disorder—Sorafenib—thyroid cancer	0.000207	0.0017	CcSEcCtD
Acitretin—Dry eye—Epirubicin—thyroid cancer	0.000204	0.00168	CcSEcCtD
Acitretin—Anorexia—Sorafenib—thyroid cancer	0.000203	0.00167	CcSEcCtD
Acitretin—Cramps of lower extremities—Epirubicin—thyroid cancer	0.000203	0.00167	CcSEcCtD
Acitretin—Oesophagitis—Epirubicin—thyroid cancer	0.000202	0.00166	CcSEcCtD
Acitretin—Vomiting—Vandetanib—thyroid cancer	0.000201	0.00165	CcSEcCtD
Acitretin—RXRG—a6b1 and a6b4 Integrin signaling—HRAS—thyroid cancer	0.0002	0.00162	CbGpPWpGaD
Acitretin—Mouth ulceration—Epirubicin—thyroid cancer	0.0002	0.00164	CcSEcCtD
Acitretin—RBP1—Retinoblastoma (RB) in Cancer—TP53—thyroid cancer	0.0002	0.00161	CbGpPWpGaD
Acitretin—Melaena—Doxorubicin—thyroid cancer	0.0002	0.00164	CcSEcCtD
Acitretin—CYP26A1—Metabolism—NDUFA13—thyroid cancer	0.0002	0.00161	CbGpPWpGaD
Acitretin—Rash—Vandetanib—thyroid cancer	0.000199	0.00164	CcSEcCtD
Acitretin—Dermatitis—Vandetanib—thyroid cancer	0.000199	0.00164	CcSEcCtD
Acitretin—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.000199	0.00163	CcSEcCtD
Acitretin—Influenza like illness—Doxorubicin—thyroid cancer	0.000199	0.00163	CcSEcCtD
Acitretin—Headache—Vandetanib—thyroid cancer	0.000198	0.00163	CcSEcCtD
Acitretin—RXRA—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000198	0.0016	CbGpPWpGaD
Acitretin—Candida infection—Doxorubicin—thyroid cancer	0.000195	0.0016	CcSEcCtD
Acitretin—Skin exfoliation—Doxorubicin—thyroid cancer	0.000195	0.0016	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000194	0.0016	CcSEcCtD
Acitretin—Hypertonia—Epirubicin—thyroid cancer	0.000194	0.00159	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—CALCB—thyroid cancer	0.000192	0.00155	CbGpPWpGaD
Acitretin—RXRG—Adipogenesis—PPARG—thyroid cancer	0.000191	0.00155	CbGpPWpGaD
Acitretin—RARG—Gene Expression—TRIM33—thyroid cancer	0.00019	0.00153	CbGpPWpGaD
Acitretin—ALB—Bile acid and bile salt metabolism—RXRA—thyroid cancer	0.000189	0.00153	CbGpPWpGaD
Acitretin—Dry eye—Doxorubicin—thyroid cancer	0.000189	0.00155	CcSEcCtD
Acitretin—RXRB—a6b1 and a6b4 Integrin signaling—HRAS—thyroid cancer	0.000188	0.00152	CbGpPWpGaD
Acitretin—Nausea—Vandetanib—thyroid cancer	0.000188	0.00154	CcSEcCtD
Acitretin—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.000188	0.00154	CcSEcCtD
Acitretin—Dyspepsia—Sorafenib—thyroid cancer	0.000188	0.00154	CcSEcCtD
Acitretin—CYP26A1—Metabolism—CHST14—thyroid cancer	0.000188	0.00152	CbGpPWpGaD
Acitretin—Oesophagitis—Doxorubicin—thyroid cancer	0.000187	0.00153	CcSEcCtD
Acitretin—Decreased appetite—Sorafenib—thyroid cancer	0.000186	0.00152	CcSEcCtD
Acitretin—Mouth ulceration—Doxorubicin—thyroid cancer	0.000185	0.00152	CcSEcCtD
Acitretin—Diabetes mellitus—Epirubicin—thyroid cancer	0.000185	0.00151	CcSEcCtD
Acitretin—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000184	0.00151	CcSEcCtD
Acitretin—Fatigue—Sorafenib—thyroid cancer	0.000184	0.00151	CcSEcCtD
Acitretin—Hepatic function abnormal—Epirubicin—thyroid cancer	0.000184	0.00151	CcSEcCtD
Acitretin—Photosensitivity—Epirubicin—thyroid cancer	0.000183	0.0015	CcSEcCtD
Acitretin—Pain—Sorafenib—thyroid cancer	0.000183	0.0015	CcSEcCtD
Acitretin—Constipation—Sorafenib—thyroid cancer	0.000183	0.0015	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—TRIM33—thyroid cancer	0.000182	0.00147	CbGpPWpGaD
Acitretin—RARG—Generic Transcription Pathway—MEN1—thyroid cancer	0.000181	0.00146	CbGpPWpGaD
Acitretin—RARA—Adipogenesis—PPARG—thyroid cancer	0.00018	0.00145	CbGpPWpGaD
Acitretin—Vascular purpura—Epirubicin—thyroid cancer	0.000179	0.00147	CcSEcCtD
Acitretin—Hypertonia—Doxorubicin—thyroid cancer	0.000179	0.00147	CcSEcCtD
Acitretin—Eczema—Epirubicin—thyroid cancer	0.000179	0.00146	CcSEcCtD
Acitretin—Eye pain—Epirubicin—thyroid cancer	0.000178	0.00146	CcSEcCtD
Acitretin—RXRG—a6b1 and a6b4 Integrin signaling—AKT1—thyroid cancer	0.000177	0.00143	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000176	0.00143	CbGpPWpGaD
Acitretin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000175	0.00143	CcSEcCtD
Acitretin—RBP1—Disease—TCF7L1—thyroid cancer	0.000174	0.0014	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—TRIM33—thyroid cancer	0.000173	0.0014	CbGpPWpGaD
Acitretin—Hot flush—Epirubicin—thyroid cancer	0.000172	0.00141	CcSEcCtD
Acitretin—Increased appetite—Epirubicin—thyroid cancer	0.000171	0.0014	CcSEcCtD
Acitretin—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000171	0.0014	CcSEcCtD
Acitretin—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.00017	0.0014	CcSEcCtD
Acitretin—Menopausal symptoms—Epirubicin—thyroid cancer	0.00017	0.0014	CcSEcCtD
Acitretin—RARB—Gene Expression—TRIM33—thyroid cancer	0.00017	0.00137	CbGpPWpGaD
Acitretin—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.00017	0.00139	CcSEcCtD
Acitretin—Urticaria—Sorafenib—thyroid cancer	0.00017	0.00139	CcSEcCtD
Acitretin—Photosensitivity—Doxorubicin—thyroid cancer	0.000169	0.00139	CcSEcCtD
Acitretin—Abdominal pain—Sorafenib—thyroid cancer	0.000169	0.00138	CcSEcCtD
Acitretin—Body temperature increased—Sorafenib—thyroid cancer	0.000169	0.00138	CcSEcCtD
Acitretin—Dermatitis bullous—Epirubicin—thyroid cancer	0.000168	0.00138	CcSEcCtD
Acitretin—Purpura—Epirubicin—thyroid cancer	0.000167	0.00137	CcSEcCtD
Acitretin—RXRB—a6b1 and a6b4 Integrin signaling—AKT1—thyroid cancer	0.000166	0.00134	CbGpPWpGaD
Acitretin—Vascular purpura—Doxorubicin—thyroid cancer	0.000166	0.00136	CcSEcCtD
Acitretin—RXRG—Generic Transcription Pathway—MEN1—thyroid cancer	0.000165	0.00134	CbGpPWpGaD
Acitretin—Eczema—Doxorubicin—thyroid cancer	0.000165	0.00136	CcSEcCtD
Acitretin—Eye pain—Doxorubicin—thyroid cancer	0.000164	0.00135	CcSEcCtD
Acitretin—Cerebrovascular accident—Epirubicin—thyroid cancer	0.000164	0.00134	CcSEcCtD
Acitretin—RXRB—Gene Expression—TRIM33—thyroid cancer	0.000163	0.00132	CbGpPWpGaD
Acitretin—RARA—Gene Expression—TRIM33—thyroid cancer	0.000163	0.00132	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—MEN1—thyroid cancer	0.000162	0.00131	CbGpPWpGaD
Acitretin—RXRA—NRF2 pathway—SLC5A5—thyroid cancer	0.000161	0.0013	CbGpPWpGaD
Acitretin—Diplopia—Epirubicin—thyroid cancer	0.00016	0.00132	CcSEcCtD
Acitretin—Osteoarthritis—Epirubicin—thyroid cancer	0.00016	0.00132	CcSEcCtD
Acitretin—Hot flush—Doxorubicin—thyroid cancer	0.000159	0.0013	CcSEcCtD
Acitretin—Increased appetite—Doxorubicin—thyroid cancer	0.000158	0.0013	CcSEcCtD
Acitretin—Migraine—Epirubicin—thyroid cancer	0.000158	0.0013	CcSEcCtD
Acitretin—Menopausal symptoms—Doxorubicin—thyroid cancer	0.000157	0.00129	CcSEcCtD
Acitretin—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000157	0.00129	CcSEcCtD
Acitretin—Hypersensitivity—Sorafenib—thyroid cancer	0.000157	0.00129	CcSEcCtD
Acitretin—RXRB—Generic Transcription Pathway—MEN1—thyroid cancer	0.000155	0.00126	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—MEN1—thyroid cancer	0.000155	0.00126	CbGpPWpGaD
Acitretin—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000155	0.00127	CcSEcCtD
Acitretin—Purpura—Doxorubicin—thyroid cancer	0.000154	0.00126	CcSEcCtD
Acitretin—Asthenia—Sorafenib—thyroid cancer	0.000153	0.00126	CcSEcCtD
Acitretin—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000152	0.00124	CcSEcCtD
Acitretin—CYP26A1—Metabolism—HPGD—thyroid cancer	0.000151	0.00122	CbGpPWpGaD
Acitretin—Pruritus—Sorafenib—thyroid cancer	0.000151	0.00124	CcSEcCtD
Acitretin—Blood creatinine increased—Epirubicin—thyroid cancer	0.00015	0.00123	CcSEcCtD
Acitretin—Diplopia—Doxorubicin—thyroid cancer	0.000148	0.00122	CcSEcCtD
Acitretin—Osteoarthritis—Doxorubicin—thyroid cancer	0.000148	0.00122	CcSEcCtD
Acitretin—Liver function test abnormal—Epirubicin—thyroid cancer	0.000148	0.00122	CcSEcCtD
Acitretin—Dry skin—Epirubicin—thyroid cancer	0.000147	0.00121	CcSEcCtD
Acitretin—Migraine—Doxorubicin—thyroid cancer	0.000146	0.0012	CcSEcCtD
Acitretin—Diarrhoea—Sorafenib—thyroid cancer	0.000146	0.0012	CcSEcCtD
Acitretin—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARG—thyroid cancer	0.000142	0.00115	CbGpPWpGaD
Acitretin—Gastritis—Epirubicin—thyroid cancer	0.000142	0.00117	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000142	0.00116	CcSEcCtD
Acitretin—Muscular weakness—Epirubicin—thyroid cancer	0.000142	0.00116	CcSEcCtD
Acitretin—Dizziness—Sorafenib—thyroid cancer	0.000141	0.00116	CcSEcCtD
Acitretin—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000139	0.00114	CcSEcCtD
Acitretin—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000137	0.00112	CcSEcCtD
Acitretin—RARG—Gene Expression—THRB—thyroid cancer	0.000137	0.00111	CbGpPWpGaD
Acitretin—Dry skin—Doxorubicin—thyroid cancer	0.000136	0.00112	CcSEcCtD
Acitretin—Pancreatitis—Epirubicin—thyroid cancer	0.000136	0.00112	CcSEcCtD
Acitretin—Vomiting—Sorafenib—thyroid cancer	0.000136	0.00111	CcSEcCtD
Acitretin—Rash—Sorafenib—thyroid cancer	0.000135	0.0011	CcSEcCtD
Acitretin—Dermatitis—Sorafenib—thyroid cancer	0.000134	0.0011	CcSEcCtD
Acitretin—Headache—Sorafenib—thyroid cancer	0.000134	0.0011	CcSEcCtD
Acitretin—Pancytopenia—Epirubicin—thyroid cancer	0.000132	0.00108	CcSEcCtD
Acitretin—Gastritis—Doxorubicin—thyroid cancer	0.000131	0.00108	CcSEcCtD
Acitretin—Muscular weakness—Doxorubicin—thyroid cancer	0.000131	0.00107	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000131	0.00107	CcSEcCtD
Acitretin—Dysuria—Epirubicin—thyroid cancer	0.00013	0.00106	CcSEcCtD
Acitretin—RXRA—Generic Transcription Pathway—THRB—thyroid cancer	0.000128	0.00103	CbGpPWpGaD
Acitretin—RBP1—Disease—TPR—thyroid cancer	0.000127	0.00103	CbGpPWpGaD
Acitretin—Nausea—Sorafenib—thyroid cancer	0.000127	0.00104	CcSEcCtD
Acitretin—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000127	0.00104	CcSEcCtD
Acitretin—Weight increased—Epirubicin—thyroid cancer	0.000126	0.00104	CcSEcCtD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000126	0.00102	CbGpPWpGaD
Acitretin—Pancreatitis—Doxorubicin—thyroid cancer	0.000126	0.00103	CcSEcCtD
Acitretin—Weight decreased—Epirubicin—thyroid cancer	0.000125	0.00103	CcSEcCtD
Acitretin—RXRG—Gene Expression—THRB—thyroid cancer	0.000125	0.00101	CbGpPWpGaD
Acitretin—RBP1—Disease—PRKAR1A—thyroid cancer	0.000125	0.00101	CbGpPWpGaD
Acitretin—RARB—Gene Expression—THRB—thyroid cancer	0.000123	0.000993	CbGpPWpGaD
Acitretin—Pancytopenia—Doxorubicin—thyroid cancer	0.000122	0.001	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—TCF7L1—thyroid cancer	0.000122	0.000984	CbGpPWpGaD
Acitretin—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000121	0.000994	CcSEcCtD
Acitretin—RARG—Generic Transcription Pathway—RXRA—thyroid cancer	0.000121	0.000977	CbGpPWpGaD
Acitretin—Stomatitis—Epirubicin—thyroid cancer	0.000121	0.000989	CcSEcCtD
Acitretin—Jaundice—Epirubicin—thyroid cancer	0.000121	0.000989	CcSEcCtD
Acitretin—Urinary tract infection—Epirubicin—thyroid cancer	0.00012	0.000986	CcSEcCtD
Acitretin—Conjunctivitis—Epirubicin—thyroid cancer	0.00012	0.000986	CcSEcCtD
Acitretin—Dysuria—Doxorubicin—thyroid cancer	0.00012	0.000985	CcSEcCtD
Acitretin—RXRA—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.00012	0.000967	CbGpPWpGaD
Acitretin—RBP1—Disease—MEN1—thyroid cancer	0.00012	0.000967	CbGpPWpGaD
Acitretin—Haematuria—Epirubicin—thyroid cancer	0.000118	0.000967	CcSEcCtD
Acitretin—RARA—Gene Expression—THRB—thyroid cancer	0.000118	0.000952	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—THRB—thyroid cancer	0.000118	0.000952	CbGpPWpGaD
Acitretin—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000117	0.000961	CcSEcCtD
Acitretin—RXRA—NRF2 pathway—NRG1—thyroid cancer	0.000117	0.000945	CbGpPWpGaD
Acitretin—Weight increased—Doxorubicin—thyroid cancer	0.000117	0.000958	CcSEcCtD
Acitretin—Epistaxis—Epirubicin—thyroid cancer	0.000117	0.000957	CcSEcCtD
Acitretin—Weight decreased—Doxorubicin—thyroid cancer	0.000116	0.000953	CcSEcCtD
Acitretin—Sinusitis—Epirubicin—thyroid cancer	0.000116	0.000952	CcSEcCtD
Acitretin—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000112	0.00092	CcSEcCtD
Acitretin—Haemoglobin—Epirubicin—thyroid cancer	0.000112	0.000915	CcSEcCtD
Acitretin—Stomatitis—Doxorubicin—thyroid cancer	0.000112	0.000915	CcSEcCtD
Acitretin—Jaundice—Doxorubicin—thyroid cancer	0.000112	0.000915	CcSEcCtD
Acitretin—Rhinitis—Epirubicin—thyroid cancer	0.000111	0.000913	CcSEcCtD
Acitretin—Urinary tract infection—Doxorubicin—thyroid cancer	0.000111	0.000912	CcSEcCtD
Acitretin—Conjunctivitis—Doxorubicin—thyroid cancer	0.000111	0.000912	CcSEcCtD
Acitretin—Haemorrhage—Epirubicin—thyroid cancer	0.000111	0.000911	CcSEcCtD
Acitretin—Hepatitis—Epirubicin—thyroid cancer	0.000111	0.000911	CcSEcCtD
Acitretin—RXRG—Generic Transcription Pathway—RXRA—thyroid cancer	0.000111	0.000894	CbGpPWpGaD
Acitretin—Hypoaesthesia—Epirubicin—thyroid cancer	0.00011	0.000906	CcSEcCtD
Acitretin—RXRA—Adipogenesis—HIF1A—thyroid cancer	0.00011	0.00089	CbGpPWpGaD
Acitretin—Pharyngitis—Epirubicin—thyroid cancer	0.00011	0.000904	CcSEcCtD
Acitretin—Oedema peripheral—Epirubicin—thyroid cancer	0.000109	0.000897	CcSEcCtD
Acitretin—Haematuria—Doxorubicin—thyroid cancer	0.000109	0.000895	CcSEcCtD
Acitretin—RARB—Generic Transcription Pathway—RXRA—thyroid cancer	0.000108	0.000876	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000108	0.000876	CbGpPWpGaD
Acitretin—Epistaxis—Doxorubicin—thyroid cancer	0.000108	0.000885	CcSEcCtD
Acitretin—Sinusitis—Doxorubicin—thyroid cancer	0.000107	0.000881	CcSEcCtD
Acitretin—RXRA—PPARA activates gene expression—PPARG—thyroid cancer	0.000107	0.000865	CbGpPWpGaD
Acitretin—Visual impairment—Epirubicin—thyroid cancer	0.000107	0.000878	CcSEcCtD
Acitretin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	0.000105	0.000847	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—RXRA—thyroid cancer	0.000104	0.00084	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—RXRA—thyroid cancer	0.000104	0.00084	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000104	0.00084	CbGpPWpGaD
Acitretin—Eye disorder—Epirubicin—thyroid cancer	0.000104	0.000851	CcSEcCtD
Acitretin—Tinnitus—Epirubicin—thyroid cancer	0.000104	0.000849	CcSEcCtD
Acitretin—Haemoglobin—Doxorubicin—thyroid cancer	0.000103	0.000847	CcSEcCtD
Acitretin—Flushing—Epirubicin—thyroid cancer	0.000103	0.000845	CcSEcCtD
Acitretin—Rhinitis—Doxorubicin—thyroid cancer	0.000103	0.000845	CcSEcCtD
Acitretin—Hepatitis—Doxorubicin—thyroid cancer	0.000103	0.000843	CcSEcCtD
Acitretin—Haemorrhage—Doxorubicin—thyroid cancer	0.000103	0.000843	CcSEcCtD
Acitretin—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000102	0.000838	CcSEcCtD
Acitretin—Pharyngitis—Doxorubicin—thyroid cancer	0.000102	0.000836	CcSEcCtD
Acitretin—Oedema peripheral—Doxorubicin—thyroid cancer	0.000101	0.00083	CcSEcCtD
Acitretin—Angiopathy—Epirubicin—thyroid cancer	0.000101	0.000826	CcSEcCtD
Acitretin—Immune system disorder—Epirubicin—thyroid cancer	0.0001	0.000823	CcSEcCtD
Acitretin—Chills—Epirubicin—thyroid cancer	9.96e-05	0.000817	CcSEcCtD
Acitretin—Visual impairment—Doxorubicin—thyroid cancer	9.9e-05	0.000812	CcSEcCtD
Acitretin—Alopecia—Epirubicin—thyroid cancer	9.81e-05	0.000805	CcSEcCtD
Acitretin—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—thyroid cancer	9.8e-05	0.000792	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	9.8e-05	0.000792	CbGpPWpGaD
Acitretin—Erythema—Epirubicin—thyroid cancer	9.66e-05	0.000793	CcSEcCtD
Acitretin—Eye disorder—Doxorubicin—thyroid cancer	9.6e-05	0.000788	CcSEcCtD
Acitretin—Tinnitus—Doxorubicin—thyroid cancer	9.58e-05	0.000786	CcSEcCtD
Acitretin—Flushing—Doxorubicin—thyroid cancer	9.53e-05	0.000782	CcSEcCtD
Acitretin—RBP1—Disease—CALCA—thyroid cancer	9.52e-05	0.00077	CbGpPWpGaD
Acitretin—Tension—Epirubicin—thyroid cancer	9.48e-05	0.000778	CcSEcCtD
Acitretin—Dysgeusia—Epirubicin—thyroid cancer	9.46e-05	0.000776	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	9.46e-05	0.000764	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	9.39e-05	0.000759	CbGpPWpGaD
Acitretin—Nervousness—Epirubicin—thyroid cancer	9.39e-05	0.00077	CcSEcCtD
Acitretin—RXRA—Adipogenesis—PPARG—thyroid cancer	9.37e-05	0.000757	CbGpPWpGaD
Acitretin—Back pain—Epirubicin—thyroid cancer	9.35e-05	0.000767	CcSEcCtD
Acitretin—Angiopathy—Doxorubicin—thyroid cancer	9.32e-05	0.000765	CcSEcCtD
Acitretin—Muscle spasms—Epirubicin—thyroid cancer	9.29e-05	0.000762	CcSEcCtD
Acitretin—Immune system disorder—Doxorubicin—thyroid cancer	9.28e-05	0.000761	CcSEcCtD
Acitretin—RARG—Gene Expression—TPR—thyroid cancer	9.26e-05	0.000748	CbGpPWpGaD
Acitretin—Chills—Doxorubicin—thyroid cancer	9.22e-05	0.000756	CcSEcCtD
Acitretin—Vision blurred—Epirubicin—thyroid cancer	9.11e-05	0.000747	CcSEcCtD
Acitretin—Alopecia—Doxorubicin—thyroid cancer	9.08e-05	0.000745	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	9.07e-05	0.000733	CbGpPWpGaD
Acitretin—Ill-defined disorder—Epirubicin—thyroid cancer	8.97e-05	0.000736	CcSEcCtD
Acitretin—Erythema—Doxorubicin—thyroid cancer	8.94e-05	0.000734	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—TSHR—thyroid cancer	8.91e-05	0.00072	CbGpPWpGaD
Acitretin—Tension—Doxorubicin—thyroid cancer	8.78e-05	0.00072	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—PRKAR1A—thyroid cancer	8.76e-05	0.000708	CbGpPWpGaD
Acitretin—Dysgeusia—Doxorubicin—thyroid cancer	8.76e-05	0.000718	CcSEcCtD
Acitretin—Malaise—Epirubicin—thyroid cancer	8.72e-05	0.000715	CcSEcCtD
Acitretin—RXRA—Metabolism—MINPP1—thyroid cancer	8.71e-05	0.000704	CbGpPWpGaD
Acitretin—RARG—Gene Expression—MEN1—thyroid cancer	8.7e-05	0.000703	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—TPR—thyroid cancer	8.69e-05	0.000702	CbGpPWpGaD
Acitretin—Nervousness—Doxorubicin—thyroid cancer	8.69e-05	0.000713	CcSEcCtD
Acitretin—RXRA—a6b1 and a6b4 Integrin signaling—AKT1—thyroid cancer	8.66e-05	0.000699	CbGpPWpGaD
Acitretin—Back pain—Doxorubicin—thyroid cancer	8.65e-05	0.00071	CcSEcCtD
Acitretin—RBP1—Disease—CDK1—thyroid cancer	8.62e-05	0.000697	CbGpPWpGaD
Acitretin—Muscle spasms—Doxorubicin—thyroid cancer	8.6e-05	0.000705	CcSEcCtD
Acitretin—CYP26A1—Metabolism—PRKAR1A—thyroid cancer	8.54e-05	0.00069	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—TRIM33—thyroid cancer	8.49e-05	0.000686	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—TPR—thyroid cancer	8.47e-05	0.000684	CbGpPWpGaD
Acitretin—Cough—Epirubicin—thyroid cancer	8.43e-05	0.000692	CcSEcCtD
Acitretin—Vision blurred—Doxorubicin—thyroid cancer	8.43e-05	0.000691	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—MEN1—thyroid cancer	8.38e-05	0.000677	CbGpPWpGaD
Acitretin—RARB—Gene Expression—TPR—thyroid cancer	8.3e-05	0.000671	CbGpPWpGaD
Acitretin—Ill-defined disorder—Doxorubicin—thyroid cancer	8.3e-05	0.000681	CcSEcCtD
Acitretin—Chest pain—Epirubicin—thyroid cancer	8.23e-05	0.000675	CcSEcCtD
Acitretin—Arthralgia—Epirubicin—thyroid cancer	8.23e-05	0.000675	CcSEcCtD
Acitretin—Myalgia—Epirubicin—thyroid cancer	8.23e-05	0.000675	CcSEcCtD
Acitretin—Anxiety—Epirubicin—thyroid cancer	8.2e-05	0.000673	CcSEcCtD
Acitretin—Discomfort—Epirubicin—thyroid cancer	8.13e-05	0.000667	CcSEcCtD
Acitretin—RXRA—Generic Transcription Pathway—MEN1—thyroid cancer	8.1e-05	0.000655	CbGpPWpGaD
Acitretin—Malaise—Doxorubicin—thyroid cancer	8.06e-05	0.000662	CcSEcCtD
Acitretin—Dry mouth—Epirubicin—thyroid cancer	8.05e-05	0.00066	CcSEcCtD
Acitretin—RXRB—Gene Expression—TPR—thyroid cancer	7.96e-05	0.000643	CbGpPWpGaD
Acitretin—RARA—Gene Expression—TPR—thyroid cancer	7.96e-05	0.000643	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—MEN1—thyroid cancer	7.96e-05	0.000643	CbGpPWpGaD
Acitretin—Oedema—Epirubicin—thyroid cancer	7.89e-05	0.000647	CcSEcCtD
Acitretin—Infection—Epirubicin—thyroid cancer	7.84e-05	0.000643	CcSEcCtD
Acitretin—RARB—Gene Expression—MEN1—thyroid cancer	7.81e-05	0.000631	CbGpPWpGaD
Acitretin—Cough—Doxorubicin—thyroid cancer	7.8e-05	0.00064	CcSEcCtD
Acitretin—Skin disorder—Epirubicin—thyroid cancer	7.66e-05	0.000629	CcSEcCtD
Acitretin—RARG—Generic Transcription Pathway—PPARG—thyroid cancer	7.63e-05	0.000617	CbGpPWpGaD
Acitretin—Hyperhidrosis—Epirubicin—thyroid cancer	7.62e-05	0.000626	CcSEcCtD
Acitretin—Myalgia—Doxorubicin—thyroid cancer	7.61e-05	0.000625	CcSEcCtD
Acitretin—Chest pain—Doxorubicin—thyroid cancer	7.61e-05	0.000625	CcSEcCtD
Acitretin—Arthralgia—Doxorubicin—thyroid cancer	7.61e-05	0.000625	CcSEcCtD
Acitretin—Anxiety—Doxorubicin—thyroid cancer	7.59e-05	0.000622	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—PTCH1—thyroid cancer	7.58e-05	0.000612	CbGpPWpGaD
Acitretin—Discomfort—Doxorubicin—thyroid cancer	7.52e-05	0.000617	CcSEcCtD
Acitretin—Anorexia—Epirubicin—thyroid cancer	7.52e-05	0.000617	CcSEcCtD
Acitretin—RARA—Gene Expression—MEN1—thyroid cancer	7.48e-05	0.000605	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—MEN1—thyroid cancer	7.48e-05	0.000605	CbGpPWpGaD
Acitretin—Dry mouth—Doxorubicin—thyroid cancer	7.45e-05	0.000611	CcSEcCtD
Acitretin—RXRA—Metabolism—NDUFA13—thyroid cancer	7.41e-05	0.000599	CbGpPWpGaD
Acitretin—Oedema—Doxorubicin—thyroid cancer	7.3e-05	0.000599	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	7.26e-05	0.000587	CbGpPWpGaD
Acitretin—Infection—Doxorubicin—thyroid cancer	7.25e-05	0.000595	CcSEcCtD
Acitretin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	7.22e-05	0.000584	CbGpPWpGaD
Acitretin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	7.19e-05	0.00059	CcSEcCtD
Acitretin—Insomnia—Epirubicin—thyroid cancer	7.13e-05	0.000585	CcSEcCtD
Acitretin—Skin disorder—Doxorubicin—thyroid cancer	7.09e-05	0.000582	CcSEcCtD
Acitretin—Paraesthesia—Epirubicin—thyroid cancer	7.08e-05	0.000581	CcSEcCtD
Acitretin—Hyperhidrosis—Doxorubicin—thyroid cancer	7.06e-05	0.000579	CcSEcCtD
Acitretin—Somnolence—Epirubicin—thyroid cancer	7.01e-05	0.000575	CcSEcCtD
Acitretin—RXRG—Generic Transcription Pathway—PPARG—thyroid cancer	6.98e-05	0.000564	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CHST14—thyroid cancer	6.97e-05	0.000563	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	6.96e-05	0.000563	CbGpPWpGaD
Acitretin—Anorexia—Doxorubicin—thyroid cancer	6.96e-05	0.000571	CcSEcCtD
Acitretin—Dyspepsia—Epirubicin—thyroid cancer	6.94e-05	0.00057	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—SST—thyroid cancer	6.93e-05	0.00056	CbGpPWpGaD
Acitretin—RBP1—Disease—NRG1—thyroid cancer	6.92e-05	0.000559	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—TPR—thyroid cancer	6.89e-05	0.000556	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—CP—thyroid cancer	6.89e-05	0.000556	CbGpPWpGaD
Acitretin—Decreased appetite—Epirubicin—thyroid cancer	6.86e-05	0.000562	CcSEcCtD
Acitretin—RARB—Generic Transcription Pathway—PPARG—thyroid cancer	6.85e-05	0.000553	CbGpPWpGaD
Acitretin—Gastrointestinal disorder—Epirubicin—thyroid cancer	6.81e-05	0.000559	CcSEcCtD
Acitretin—Fatigue—Epirubicin—thyroid cancer	6.8e-05	0.000558	CcSEcCtD
Acitretin—RXRA—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	6.77e-05	0.000547	CbGpPWpGaD
Acitretin—Pain—Epirubicin—thyroid cancer	6.74e-05	0.000553	CcSEcCtD
Acitretin—Constipation—Epirubicin—thyroid cancer	6.74e-05	0.000553	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—CALCA—thyroid cancer	6.67e-05	0.000539	CbGpPWpGaD
Acitretin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	6.65e-05	0.000545	CcSEcCtD
Acitretin—Insomnia—Doxorubicin—thyroid cancer	6.6e-05	0.000542	CcSEcCtD
Acitretin—RXRB—Generic Transcription Pathway—PPARG—thyroid cancer	6.56e-05	0.00053	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—PPARG—thyroid cancer	6.56e-05	0.00053	CbGpPWpGaD
Acitretin—Paraesthesia—Doxorubicin—thyroid cancer	6.55e-05	0.000538	CcSEcCtD
Acitretin—CYP26A1—Metabolism—SLC5A5—thyroid cancer	6.5e-05	0.000525	CbGpPWpGaD
Acitretin—Feeling abnormal—Epirubicin—thyroid cancer	6.5e-05	0.000533	CcSEcCtD
Acitretin—Somnolence—Doxorubicin—thyroid cancer	6.49e-05	0.000532	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	6.45e-05	0.000521	CbGpPWpGaD
Acitretin—Gastrointestinal pain—Epirubicin—thyroid cancer	6.45e-05	0.000529	CcSEcCtD
Acitretin—Dyspepsia—Doxorubicin—thyroid cancer	6.42e-05	0.000527	CcSEcCtD
Acitretin—Decreased appetite—Doxorubicin—thyroid cancer	6.34e-05	0.00052	CcSEcCtD
Acitretin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	6.3e-05	0.000517	CcSEcCtD
Acitretin—Fatigue—Doxorubicin—thyroid cancer	6.29e-05	0.000516	CcSEcCtD
Acitretin—Urticaria—Epirubicin—thyroid cancer	6.27e-05	0.000514	CcSEcCtD
Acitretin—Pain—Doxorubicin—thyroid cancer	6.24e-05	0.000512	CcSEcCtD
Acitretin—Constipation—Doxorubicin—thyroid cancer	6.24e-05	0.000512	CcSEcCtD
Acitretin—Body temperature increased—Epirubicin—thyroid cancer	6.24e-05	0.000512	CcSEcCtD
Acitretin—Abdominal pain—Epirubicin—thyroid cancer	6.24e-05	0.000512	CcSEcCtD
Acitretin—RBP1—Disease—TERT—thyroid cancer	6.21e-05	0.000502	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	6.19e-05	0.0005	CbGpPWpGaD
Acitretin—ALB—SLC-mediated transmembrane transport—CP—thyroid cancer	6.18e-05	0.000499	CbGpPWpGaD
Acitretin—ALB—SLC-mediated transmembrane transport—TPR—thyroid cancer	6.18e-05	0.000499	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—THRB—thyroid cancer	6.14e-05	0.000496	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CDK1—thyroid cancer	6.04e-05	0.000488	CbGpPWpGaD
Acitretin—Feeling abnormal—Doxorubicin—thyroid cancer	6.01e-05	0.000493	CcSEcCtD
Acitretin—Gastrointestinal pain—Doxorubicin—thyroid cancer	5.97e-05	0.00049	CcSEcCtD
Acitretin—RBP1—Disease—HIF1A—thyroid cancer	5.94e-05	0.00048	CbGpPWpGaD
Acitretin—RARG—Gene Expression—RXRA—thyroid cancer	5.82e-05	0.00047	CbGpPWpGaD
Acitretin—Hypersensitivity—Epirubicin—thyroid cancer	5.81e-05	0.000477	CcSEcCtD
Acitretin—Urticaria—Doxorubicin—thyroid cancer	5.8e-05	0.000476	CcSEcCtD
Acitretin—Body temperature increased—Doxorubicin—thyroid cancer	5.77e-05	0.000473	CcSEcCtD
Acitretin—Abdominal pain—Doxorubicin—thyroid cancer	5.77e-05	0.000473	CcSEcCtD
Acitretin—ALB—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	5.75e-05	0.000465	CbGpPWpGaD
Acitretin—Asthenia—Epirubicin—thyroid cancer	5.66e-05	0.000464	CcSEcCtD
Acitretin—RXRA—Metabolism—HPGD—thyroid cancer	5.62e-05	0.000454	CbGpPWpGaD
Acitretin—Pruritus—Epirubicin—thyroid cancer	5.58e-05	0.000458	CcSEcCtD
Acitretin—RXRA—Developmental Biology—CDK1—thyroid cancer	5.49e-05	0.000444	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—RXRA—thyroid cancer	5.46e-05	0.000441	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	5.45e-05	0.00044	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	5.42e-05	0.000438	CbGpPWpGaD
Acitretin—Diarrhoea—Epirubicin—thyroid cancer	5.4e-05	0.000443	CcSEcCtD
Acitretin—Hypersensitivity—Doxorubicin—thyroid cancer	5.38e-05	0.000441	CcSEcCtD
Acitretin—RXRG—Gene Expression—RXRA—thyroid cancer	5.32e-05	0.00043	CbGpPWpGaD
Acitretin—Asthenia—Doxorubicin—thyroid cancer	5.24e-05	0.00043	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	5.23e-05	0.000422	CbGpPWpGaD
Acitretin—RARB—Gene Expression—RXRA—thyroid cancer	5.22e-05	0.000422	CbGpPWpGaD
Acitretin—Dizziness—Epirubicin—thyroid cancer	5.22e-05	0.000428	CcSEcCtD
Acitretin—Pruritus—Doxorubicin—thyroid cancer	5.16e-05	0.000424	CcSEcCtD
Acitretin—RXRA—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.16e-05	0.000417	CbGpPWpGaD
Acitretin—Vomiting—Epirubicin—thyroid cancer	5.01e-05	0.000411	CcSEcCtD
Acitretin—RXRB—Gene Expression—RXRA—thyroid cancer	5.01e-05	0.000404	CbGpPWpGaD
Acitretin—RARA—Gene Expression—RXRA—thyroid cancer	5.01e-05	0.000404	CbGpPWpGaD
Acitretin—Diarrhoea—Doxorubicin—thyroid cancer	4.99e-05	0.00041	CcSEcCtD
Acitretin—Rash—Epirubicin—thyroid cancer	4.97e-05	0.000408	CcSEcCtD
Acitretin—Dermatitis—Epirubicin—thyroid cancer	4.97e-05	0.000408	CcSEcCtD
Acitretin—Headache—Epirubicin—thyroid cancer	4.94e-05	0.000405	CcSEcCtD
Acitretin—RBP1—Disease—BRAF—thyroid cancer	4.92e-05	0.000398	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	4.9e-05	0.000396	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—NRG1—thyroid cancer	4.85e-05	0.000392	CbGpPWpGaD
Acitretin—Dizziness—Doxorubicin—thyroid cancer	4.83e-05	0.000396	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	4.73e-05	0.000382	CbGpPWpGaD
Acitretin—Nausea—Epirubicin—thyroid cancer	4.69e-05	0.000384	CcSEcCtD
Acitretin—Vomiting—Doxorubicin—thyroid cancer	4.64e-05	0.000381	CcSEcCtD
Acitretin—ALB—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	4.63e-05	0.000374	CbGpPWpGaD
Acitretin—Rash—Doxorubicin—thyroid cancer	4.6e-05	0.000377	CcSEcCtD
Acitretin—Dermatitis—Doxorubicin—thyroid cancer	4.6e-05	0.000377	CcSEcCtD
Acitretin—ALB—Selenium Micronutrient Network—PTGS2—thyroid cancer	4.59e-05	0.000371	CbGpPWpGaD
Acitretin—Headache—Doxorubicin—thyroid cancer	4.57e-05	0.000375	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—TERT—thyroid cancer	4.35e-05	0.000352	CbGpPWpGaD
Acitretin—Nausea—Doxorubicin—thyroid cancer	4.33e-05	0.000356	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—HIF1A—thyroid cancer	4.16e-05	0.000336	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—TPR—thyroid cancer	4.15e-05	0.000335	CbGpPWpGaD
Acitretin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	4.02e-05	0.000325	CbGpPWpGaD
Acitretin—ALB—Metabolism—MINPP1—thyroid cancer	3.97e-05	0.000321	CbGpPWpGaD
Acitretin—RBP1—Disease—PTGS2—thyroid cancer	3.97e-05	0.000321	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MEN1—thyroid cancer	3.9e-05	0.000315	CbGpPWpGaD
Acitretin—RARG—Gene Expression—PPARG—thyroid cancer	3.68e-05	0.000297	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	3.63e-05	0.000293	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PRKAR1A—thyroid cancer	3.57e-05	0.000288	CbGpPWpGaD
Acitretin—RBP1—Disease—PTEN—thyroid cancer	3.47e-05	0.00028	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PPARG—thyroid cancer	3.45e-05	0.000279	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—BRAF—thyroid cancer	3.45e-05	0.000278	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—TP53—thyroid cancer	3.44e-05	0.000278	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—PPARG—thyroid cancer	3.42e-05	0.000276	CbGpPWpGaD
Acitretin—ALB—Metabolism—NDUFA13—thyroid cancer	3.38e-05	0.000273	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—PPARG—thyroid cancer	3.36e-05	0.000272	CbGpPWpGaD
Acitretin—RARB—Gene Expression—PPARG—thyroid cancer	3.3e-05	0.000266	CbGpPWpGaD
Acitretin—RXRA—Metabolism—TPR—thyroid cancer	3.23e-05	0.000261	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	3.22e-05	0.000261	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—PPARG—thyroid cancer	3.22e-05	0.00026	CbGpPWpGaD
Acitretin—ALB—Metabolism—CHST14—thyroid cancer	3.18e-05	0.000257	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PRKAR1A—thyroid cancer	3.17e-05	0.000256	CbGpPWpGaD
Acitretin—RARA—Gene Expression—PPARG—thyroid cancer	3.16e-05	0.000255	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—PPARG—thyroid cancer	3.16e-05	0.000255	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—TPR—thyroid cancer	3.14e-05	0.000254	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—CP—thyroid cancer	3.14e-05	0.000254	CbGpPWpGaD
Acitretin—RBP1—Disease—NRAS—thyroid cancer	3.09e-05	0.00025	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.09e-05	0.00025	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.88e-05	0.000232	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	2.72e-05	0.00022	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTGS2—thyroid cancer	2.71e-05	0.000219	CbGpPWpGaD
Acitretin—RBP1—Disease—KRAS—thyroid cancer	2.66e-05	0.000215	CbGpPWpGaD
Acitretin—ALB—Metabolism—HPGD—thyroid cancer	2.56e-05	0.000207	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CCND1—thyroid cancer	2.51e-05	0.000203	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PTEN—thyroid cancer	2.43e-05	0.000196	CbGpPWpGaD
Acitretin—RXRA—Metabolism—SLC5A5—thyroid cancer	2.41e-05	0.000195	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTEN—thyroid cancer	2.37e-05	0.000191	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IFNA2—thyroid cancer	2.36e-05	0.000191	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.35e-05	0.00019	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.26e-05	0.000183	CbGpPWpGaD
Acitretin—RBP1—Disease—HRAS—thyroid cancer	2.26e-05	0.000183	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—NRAS—thyroid cancer	2.17e-05	0.000175	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.08e-05	0.000168	CbGpPWpGaD
Acitretin—RBP1—Disease—AKT1—thyroid cancer	2e-05	0.000161	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.98e-05	0.00016	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.97e-05	0.000159	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—NRAS—thyroid cancer	1.97e-05	0.000159	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—KRAS—thyroid cancer	1.86e-05	0.000151	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—KRAS—thyroid cancer	1.7e-05	0.000137	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TP53—thyroid cancer	1.66e-05	0.000134	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—PPARG—thyroid cancer	1.65e-05	0.000133	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—HRAS—thyroid cancer	1.58e-05	0.000128	CbGpPWpGaD
Acitretin—ALB—Metabolism—TPR—thyroid cancer	1.47e-05	0.000119	CbGpPWpGaD
Acitretin—RARG—Gene Expression—AKT1—thyroid cancer	1.45e-05	0.000117	CbGpPWpGaD
Acitretin—ALB—Metabolism—PRKAR1A—thyroid cancer	1.45e-05	0.000117	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—HRAS—thyroid cancer	1.44e-05	0.000117	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—AKT1—thyroid cancer	1.4e-05	0.000113	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—AKT1—thyroid cancer	1.36e-05	0.00011	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—AKT1—thyroid cancer	1.33e-05	0.000107	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.31e-05	0.000106	CbGpPWpGaD
Acitretin—RARB—Gene Expression—AKT1—thyroid cancer	1.3e-05	0.000105	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PPARG—thyroid cancer	1.28e-05	0.000103	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—AKT1—thyroid cancer	1.27e-05	0.000103	CbGpPWpGaD
Acitretin—RARA—Gene Expression—AKT1—thyroid cancer	1.25e-05	0.000101	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—AKT1—thyroid cancer	1.25e-05	0.000101	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	1.11e-05	8.93e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC5A5—thyroid cancer	1.1e-05	8.9e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.03e-05	8.34e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTGS2—thyroid cancer	1.01e-05	8.14e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—RXRA—thyroid cancer	9.25e-06	7.48e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9e-06	7.27e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—NRAS—thyroid cancer	8.82e-06	7.13e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTEN—thyroid cancer	8.79e-06	7.1e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—KRAS—thyroid cancer	7.59e-06	6.13e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TP53—thyroid cancer	6.75e-06	5.45e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—AKT1—thyroid cancer	6.51e-06	5.26e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—HRAS—thyroid cancer	6.45e-06	5.21e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PPARG—thyroid cancer	5.84e-06	4.72e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—AKT1—thyroid cancer	5.7e-06	4.6e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—AKT1—thyroid cancer	5.06e-06	4.09e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTGS2—thyroid cancer	4.6e-06	3.71e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTEN—thyroid cancer	4.01e-06	3.24e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—AKT1—thyroid cancer	2.31e-06	1.87e-05	CbGpPWpGaD
